151 related articles for article (PubMed ID: 38146732)
41. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
[TBL] [Abstract][Full Text] [Related]
42. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas.
Asa SL; Puy LA; Lew AM; Sundmark VC; Elsholtz HP
J Clin Endocrinol Metab; 1993 Nov; 77(5):1275-80. PubMed ID: 8077321
[TBL] [Abstract][Full Text] [Related]
43. [Homeoproteins and pituitary adenoma].
Barlier A; Pellegrini-Bouiller I; Gunz G; Jaquet P; Enjalbert A
Ann Endocrinol (Paris); 1997; 58(1):3-10. PubMed ID: 9207961
[TBL] [Abstract][Full Text] [Related]
44. Pituitary dwarfism in the R271W Pit-1 gene mutation.
Aarskog D; Eiken HG; Bjerknes R; Myking OL
Eur J Pediatr; 1997 Nov; 156(11):829-34. PubMed ID: 9392392
[TBL] [Abstract][Full Text] [Related]
45. Executive summary of the consensus document on hypophysitis of the Neuroendocrinology Area of Knowledge of the Spanish Society of Endocrinology and Nutrition.
Iglesias P; Biagetti B; Guerrero-Pérez F; Vicente A; Cordido F; Díez JJ;
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():116-125. PubMed ID: 36894450
[TBL] [Abstract][Full Text] [Related]
46. The R271W mutant form of Pit-1 does not act as a dominant inhibitor of Pit-1 action to activate the promoters of GH and prolactin genes.
Kishimoto M; Okimura Y; Fumoto M; Iguchi G; Iida K; Kaji H; Chihara K
Eur J Endocrinol; 2003 Jun; 148(6):619-25. PubMed ID: 12773133
[TBL] [Abstract][Full Text] [Related]
47. Reduction in hypophyseal growth hormone and prolactin expression due to deficiency in ghrelin receptor signaling is associated with Pit-1 suppression: relevance to the immune system.
Yang H; Dixit VD; Patel K; Vandanmagsar B; Collins G; Sun Y; Smith RG; Taub DD
Brain Behav Immun; 2008 Nov; 22(8):1138-45. PubMed ID: 18602461
[TBL] [Abstract][Full Text] [Related]
48. [Progress on pituitary-specific transcription factor (POU1F1) in poultry].
Jiang RS; Yang N
Yi Chuan; 2004 Nov; 26(6):957-61. PubMed ID: 15640133
[TBL] [Abstract][Full Text] [Related]
49. [Clinical analysis of paraneoplastic neurological syndrome associated with thymoma].
Liu HS; Ren HT; Zhou LX; Li SQ; Peng B; Cui LY; Guan HZ
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(35):2770-2774. PubMed ID: 28954337
[No Abstract] [Full Text] [Related]
50. Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlates.
Vallette-Kasic S; Pellegrini-Bouiller I; Sampieri F; Gunz G; Diaz A; Radovick S; Enjalbert A; Brue T
Mol Endocrinol; 2001 Mar; 15(3):411-20. PubMed ID: 11222742
[TBL] [Abstract][Full Text] [Related]
51. Onco-immuno-endocrinology: An emerging concept that links tumor, autoimmunity, and endocrine disease.
Takahashi Y
Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101666. PubMed ID: 35577694
[No Abstract] [Full Text] [Related]
52. In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas.
Sanno N; Teramoto A; Matsuno A; Itoh J; Takekoshi S; Osamura RY
Acta Neuropathol; 1996; 91(3):263-8. PubMed ID: 8834538
[TBL] [Abstract][Full Text] [Related]
53. The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors.
Ben-Batalla I; Seoane S; Macia M; Garcia-Caballero T; Gonzalez LO; Vizoso F; Perez-Fernandez R
Endocr Relat Cancer; 2010 Mar; 17(1):73-85. PubMed ID: 19808898
[TBL] [Abstract][Full Text] [Related]
54. Vitamin D, Pit-1, GH, and PRL: possible roles in breast cancer development.
Perez-Fernandez R; Seoane S; Garcia-Caballero T; Segura C; Macia M
Curr Med Chem; 2007; 14(29):3051-8. PubMed ID: 18220741
[TBL] [Abstract][Full Text] [Related]
55. GH and TSH deficiency.
Pfäffle RW; Martinez R; Kim C; Frisch H; Lebl J; Otten B; Heimann G
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():1-5. PubMed ID: 9439906
[TBL] [Abstract][Full Text] [Related]
56. The combination of Pit-1 and Pit-1T have a synergistic stimulatory effect on the thyrotropin beta-subunit promoter but not the growth hormone or prolactin promoters.
Haugen BR; Gordon DF; Nelson AR; Wood WM; Ridgway EC
Mol Endocrinol; 1994 Nov; 8(11):1574-82. PubMed ID: 7877626
[TBL] [Abstract][Full Text] [Related]
57. Immune checkpoint inhibitor-related hypophysitis.
Mizukoshi T; Fukuoka H; Takahashi Y
Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101668. PubMed ID: 35562229
[TBL] [Abstract][Full Text] [Related]
58. Lymphocytic hypophysitis in the elderly.
Sellayah R; Gonzales M; Fourlanos S; King J
J Clin Neurosci; 2015 Nov; 22(11):1842-3. PubMed ID: 26094558
[TBL] [Abstract][Full Text] [Related]
59. Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon.
Tordjman KM; Greenman Y; Ram Z; Hershkovitz D; Aizenstein O; Ariel O; Asa SL
Endocr Pathol; 2019 Mar; 30(1):74-80. PubMed ID: 30610567
[TBL] [Abstract][Full Text] [Related]
60. An autopsy case study of lymphocytic hypophysitis induced by nivolumab treatment for esophageal malignant melanoma.
Okabe N; Kobayashi T; Furuse J; Fujiwara M; Kamma H
Pathol Int; 2021 Dec; 71(12):831-836. PubMed ID: 34506687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
